TNF and neoplasm: Based on such tumor-promoting aspects of TNFR1, efforts have been made to target TNF-α or TNFR1 in various malignancies with pharmaceuticals that include TNF-α inhibitors, TNFR1 monoclonal antibodies, and TNFR1-targeting nanomaterials.